Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Structure/function claim notice for similar products "needs clarification" -- Lederle exec.

This article was originally published in The Tan Sheet

Executive Summary

STRUCTURE/FUNCTION CLAIM NOTICE REQUIREMENT FOR SIMILAR PRODUCTS "needs clarification," Lederle Consumer Associate Director of Regulatory Affairs Norma Skolnik said at a May 22-24 Functional Foods for Health retreat in Itasca, Ill. Skolnik noted that the 30-day notice requirement for structure/function claims "is a post-marketing notice and covers claims being made for the first time, and it is not clear whether marketing subsequent brands with [similar] formulations with the same claims would require additional notices to FDA."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083883

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel